MENU
ACIU
AS OF
Dec 24 closing price
Price
$3.13
Change
-$0.02 (-0.63%)
Capitalization
314.88M
77 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AC Immune SA (ACIU) Ownership - Who owns AC Immune SA?

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
314.88M
P/E Ratio
N/A
Total Cash
108.47M
Projected Growth
N/A
Total Debt
4.66M
Revenue
4.37M
Risk (Beta)
3.63
Dividend Yield
N/A
Total Cash/Share
1.08
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price

Fundamentals

ACIU
Capitalization
315M
P/E Ratio
N/A
Risk (Beta)
3.63
Dividend Yield
N/A
Total Cash
108M
Total Cash/Share
1.08
Total Debt
4.66M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.06%
Revenue
4.37M
ROE
N/A
Book Value
62.4M
P/B Ratio
3.97
Cash Flow
N/A
Earnings
-0.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.24M
Current Ratio
1.16
Current Revenue Per Employee
5459.30
Dividends Per Share - Security
N/A
EBITDA
-69.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.57
Shares Held By Institutions
74.7M
Shares Outstanding - Current
101M
Total Liabilities
109M
Total Volume MTD
N/A
Value
N/A
Gain YTD
15.926
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ACIU
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACIU showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ACIU
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com